UAE market indices at close

Friday, 6 November 2026 ·

Dubai Financial Market Index

6,025.55

-17.10 / -0.28%

Exchange summary (trading totals unavailable)

Trading volume
—
Traded value (AED)
—
Number of trades
—

FTSE ADX General Index (FADGI)

9,392.60

-127.22 / -1.34%

Exchange summary (trading totals unavailable)

Trading volume
—
Traded value (AED)
—
Number of trades
—

Dated session snapshot, not a live feed. Whole-exchange trading totals were not supplied for this session.

GoFinsa

Welcome to GoFinsa!

National International Co.

NIH

National International Co. stock (NIH) price and technical analysis

GoFinsa tracks National International Co. under symbol NIH. This page includes multi-timeframe charts, technical analysis and related market news.

Market data source: Twelve Data · Delayed market data

Primary-source research profile

National International Holding (NIH) on DFM: Portfolio, Disclosures and Risks

Sources reviewed:

Informational and educational research, not an investment recommendation. Analytical paragraphs are distinguished from sourced facts. The source-review date is not a price timestamp or a guarantee that offers remain current.

This research profile concerns National International Holding in the context of its NIH listing on Dubai Financial Market. The company is Kuwaiti; a Dubai listing does not change its place of incorporation. Sourced corporate information is separated from analytical questions about its portfolio and disclosures. This profile assigns neither an investment score nor a target price.[N1][N5]

Company identity and the two listings

From the sources

The company dates its establishment to 14 January 1979, its Kuwait listing to 11 January 2005 and its Dubai listing to 14 November 2016. These are corporate-history dates, not timestamps for the market prices displayed by GoFinsa.[N1]

Analytical perspective

Identify the venue, currency and trade timestamp before comparing quotations. A Kuwait price, volume or support level should not be transplanted into a Dubai table merely because the issuer is the same. Different observation times, currencies and liquidity can invalidate an apparent comparison. An unexplained price gap is not by itself an executable opportunity.

Information limits

This profile does not establish whether shares can be transferred between venues or what such a transfer would cost. Custody, settlement and fees require separate confirmation before any action. The research does not rewrite the symbol or technical country field in the website database.

Map the activities rather than relying on the holding-company label

From the sources

The official website describes investment exposure across financial services, property, industry, contracting, information technology, and leisure and tourism. That list identifies areas of activity; it does not establish their current portfolio weights or contributions to earnings.[N4]

Analytical perspective

Turn the list into a reviewable map: identify the asset, its manager, the economic interest, the last valuation date and the available exit route. Different sector labels do not necessarily mean independent risks. Several holdings can depend on the same funding conditions or property cycle. Look through the labels to the drivers of cash generation.

Published examples and their limits

From the sources

The portfolio pages describe Ahlia Chemicals in construction materials, Coast Investment and Development in investment activities, Weinig in woodworking equipment, and Salayl Al Jahra in tourism. These examples help identify types of exposure, not verified current ownership percentages or valuations.[N2]

Information limits

The portfolio page mixes historical and undated information. Ownership percentages, employee counts and asset totals shown there have not been reproduced as current facts. Use a dated disclosure for the period being studied to establish those figures. A corporate presentation is a starting point for research, not a substitute for reconciled reporting.[N2]

Analytical perspective

A useful review can use different questions for each exposure: customer demand and receivables for industry, occupancy and costs for property or tourism, and valuation and exit options for financial investments. These are research questions, not assertions that any named holding currently has a particular problem.

Read the statements with the reporting period in view

From the sources

The investor-relations page provides periodic and annual statement links, disclosures and governance material. The reviewed index includes first-quarter and first-half 2026 entries. The presence of a download link is not a claim that every figure or the auditor’s conclusion in that document has been independently checked here.[N3]

Analytical perspective

For any comparison, first record the period, consolidation scope and reporting unit. Do not compare a stand-alone quarter with a cumulative half-year, or group profit with profit attributable to shareholders, without reconciling the difference. Keep the notes alongside the primary statements: they can explain a large movement that the headline figure does not explain.

Separate earnings sources from available cash

Analytical perspective

Build an earnings bridge for the holding company: consider distributions, disposals, valuation changes, investee contributions, operating costs and financing. The question is not simply whether profit rose, but which component could recur and which depends on a transaction or valuation. This framework does not assert that NIH recorded any particular amount in those categories.

Hypothetical illustration

If a hypothetical investment rises in carrying value without being sold, an accounting measure may improve without a matching cash inflow. If an investment is sold for cash, ask whether the proceeds represent recurring operations or a reduction of the portfolio. This example illustrates a distinction; it is not a reported NIH transaction.

Liquidity at the parent-company level

Analytical perspective

Large assets held by investees do not automatically establish the parent’s ability to meet obligations. Examine usable cash, debt maturities, guarantees and the route by which distributions reach the holding company. Owning an interest in another business does not mean its bank balances are immediately available to the shareholder.

Analytical perspective

Test what happens if receipts or disposals arrive later than expected rather than relying on the most optimistic liquidity scenario. Organize obligations by near- and medium-term maturity instead of treating them as a single undifferentiated balance. This is an analytical method, not a diagnosis of the company’s leverage or a statement that it is in default.

Governance and shareholder questions

From the sources

The governance section sets out principles concerning board responsibilities, reporting integrity, risk management, disclosure and shareholder rights. These describe the company’s stated framework, not an independent certification that every principle has been effectively implemented in every situation.[N3]

Analytical perspective

Connect those principles to evidence such as meeting resolutions, related-party disclosures, conflicts of interest and explanations of significant transactions. Minority ownership does not eliminate the need for clear information. When reviewing a possible distribution, distinguish a board proposal from an approved resolution and the relevant entitlement date.

Build a comparison without inventing a target price

Analytical perspective

Comparing net portfolio value with market valuation can be useful only after reconciling valuation dates, liabilities, costs and non-controlling interests. Do not add unrelated historical figures and label the total current net assets. Where assets are not actively traded, explain valuation uncertainty rather than presenting false numerical precision.

Information limits

This profile does not calculate a net-asset discount, dividend yield, earnings multiple or new GFSI score. Figures in the market cards remain separate from this research and should be read with their own dates and source descriptions. General explanation cannot replace the financial disclosure needed for a valuation.

Research checklist and scope

Analytical perspective

Keep a dated disclosure file and track portfolio changes, earnings sources, liquidity, obligations and decisions affecting shareholders. A useful conclusion states what the documents support and what still requires investigation. It should not treat a rising share price as equivalent to improving investment quality.

Information limits

This is informational and educational material, not a personal instruction to buy or sell. Corporate overview pages may lag disclosures. Current portfolio weights, trade execution and distribution entitlement are not certified here. Consult the relevant reports and service provider for the intended action; advertising on the page is not evidence that the stock is suitable.

Frequently asked questions

Is National International Holding an Emirati company?

Its official profile identifies it as a Kuwaiti company with a Dubai listing. Incorporation and trading venue are different attributes.[N5]

Can Dubai and Kuwait quotations be used interchangeably?

No. Check currency, venue, timestamp and liquidity. One listing’s data should not be relabelled as the other without verification.

Does this profile add a recommendation or rating?

No. It explains the business and disclosure-review questions without assigning a target price, score or expected distribution.

Primary sources and verification references

Issuer announcements describe their position at the stated date. Distinguish historical results from forecasts and consult the original source for subsequent changes.

  1. [N1] NIH: corporate profile and listing history
  2. [N2] NIH: investment portfolio descriptions
  3. [N3] NIH: financial statements, disclosures and governance
  4. [N4] NIH: activities described on the official website
  5. [N5] DFM: National International Holding Company (NIH)

Frequently asked questions about National International Co. (NIH)

What is the price of National International Co. (NIH)?

A current market price is not available for this instrument on GoFinsa.

What does the technical analysis for National International Co. (NIH) show?

There is currently insufficient data to produce technical analysis for this instrument.

What is the GoFinsa.com General Index for National International Co.?

The GoFinsa.com General Index is currently unavailable for this instrument.